Necdin, a p53-target gene, is an inhibitor of p53-mediated growth arrest.

PloS One
Julie LafontaineAnne-Marie Mes-Masson

Abstract

In vitro, cellular immortalization and transformation define a model for multistep carcinogenesis and current ongoing challenges include the identification of specific molecular events associated with steps along this oncogenic pathway. Here, using NIH3T3 cells, we identified transcriptionally related events associated with the expression of Polyomavirus Large-T antigen (PyLT), a potent viral oncogene. We propose that a subset of these alterations in gene expression may be related to the early events that contribute to carcinogenesis. The proposed tumor suppressor Necdin, known to be regulated by p53, was within a group of genes that was consistently upregulated in the presence of PyLT. While Necdin is induced following p53 activation with different genotoxic stresses, Necdin induction by PyLT did not involve p53 activation or the Rb-binding site of PyLT. Necdin depletion by shRNA conferred a proliferative advantage to NIH3T3 and PyLT-expressing NIH3T3 (NIHLT) cells. In contrast, our results demonstrate that although overexpression of Necdin induced a growth arrest in NIH3T3 and NIHLT cells, a growing population rapidly emerged from these arrested cells. This population no longer showed significant proliferation defects despite...Continue Reading

References

Aug 21, 1992·Brain Research. Developmental Brain Research·T AizawaK Yoshikawa
Mar 1, 1991·Molecular and Cellular Biology·G G HicksM Mowat
Apr 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·W S el-DeiryS B Baylin
Jul 15, 1991·Biochemical and Biophysical Research Communications·K MaruyamaK Yoshikawa
Jan 1, 1989·Journal of Virology·G LoeberP Tegtmeyer
Mar 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·H Rubin, K Xu
Jan 1, 1984·Pharmacology & Therapeutics·C Basilico
Aug 4, 1995·Biochemical and Biophysical Research Communications·Y HayashiK Yoshikawa
Aug 29, 1995·Proceedings of the National Academy of Sciences of the United States of America·M L AgarwalG R Stark
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·O V GjørupB S Schaffhausen
Jul 1, 1994·Experimental Cell Research·M Lebel, A M Mes-Masson
Dec 1, 1993·Molecular and Cellular Biology·J A LeesK Helin
Jul 1, 1993·Genes & Development·X WuA J Levine
Sep 17, 1996·Proceedings of the National Academy of Sciences of the United States of America·V S OssovskayaA V Gudkov
Dec 1, 1995·Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research·M LebelA M Mes-Masson
Jan 23, 1999·Oncogene·N Ghebranious, L A Donehower
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·P TamayoT R Golub
May 29, 1999·The Journal of Biological Chemistry·H TaniuraK Yoshikawa
Nov 17, 1999·Molecular Biology of the Cell·W R TaylorG R Stark
Dec 2, 1999·The Journal of General Virology·A Marti, K Ballmer-Hofer
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
May 9, 2000·Journal of Virology·Q ShengB Schaffhausen
May 29, 2000·Molecular and Cellular Biology·P M FlattJ A Pietenpol
Nov 7, 2000·Current Opinion in Cell Biology·A S LundbergR A Weinberg
Feb 24, 2001·Proceedings of the National Academy of Sciences of the United States of America·M J O'HareP S Jat

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
transfection
flow cytometry
PCR
FACS
ELISA

Software Mentioned

Genespring
PyLT
GENESPRINGâ¢
Affymetrix GeneChip
RTprimerDB

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

BK Virus Infection

BK virus infection is a significant complication of modern immunosuppression used in kidney transplantation. Discover the latest research on BK virus infection here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.